SIRT6型
葡萄糖稳态
NAD+激酶
能量稳态
转基因小鼠
平衡
生物
锡尔图因
内分泌学
长寿
体内
转基因
内科学
脂肪组织
生物化学
医学
胰岛素
胰岛素抵抗
酶
基因
遗传学
肥胖
作者
Asael Roichman,Sivan Elhanati,Miguel A. Aon,Ifat Abramovich,Andrea Di Francesco,Yael Shahar,Matan Y. Avivi,Maor Shurgi,Ariel M. Rubinstein,Yosri Wiesner,A. Shuchami,Zachary Petrover,Ilana Lebenthal-Loinger,Orly Yaron,Alexey E. Lyashkov,Ceereena Ubaida-Mohien,Yariv Kanfi,Batia Lerrer,Pablo J. Fernandez-Marcos,Manuel Serrano,Eyal Gottlieb,Rafael de Cabo,Haim Y. Cohen
标识
DOI:10.1038/s41467-021-23545-7
摘要
Abstract Aging leads to a gradual decline in physical activity and disrupted energy homeostasis. The NAD + -dependent SIRT6 deacylase regulates aging and metabolism through mechanisms that largely remain unknown. Here, we show that SIRT6 overexpression leads to a reduction in frailty and lifespan extension in both male and female B6 mice. A combination of physiological assays, in vivo multi-omics analyses and 13 C lactate tracing identified an age-dependent decline in glucose homeostasis and hepatic glucose output in wild type mice. In contrast, aged SIRT6-transgenic mice preserve hepatic glucose output and glucose homeostasis through an improvement in the utilization of two major gluconeogenic precursors, lactate and glycerol. To mediate these changes, mechanistically, SIRT6 increases hepatic gluconeogenic gene expression, de novo NAD + synthesis, and systemically enhances glycerol release from adipose tissue. These findings show that SIRT6 optimizes energy homeostasis in old age to delay frailty and preserve healthy aging.
科研通智能强力驱动
Strongly Powered by AbleSci AI